Advances in periodontal biomarkers.

Biomarker Diagnosis Gingivitis Periodontitis Treatment

Journal

Advances in clinical chemistry
ISSN: 2162-9471
Titre abrégé: Adv Clin Chem
Pays: United States
ID NLM: 2985173R

Informations de publication

Date de publication:
2024
Historique:
medline: 19 5 2024
pubmed: 19 5 2024
entrez: 18 5 2024
Statut: ppublish

Résumé

Due to technologic advancements, periodontology has witnessed a boost in biomarker research over the past three decades. Indeed, with the aid of omics, our understanding of the healthy periodontium, pathogenesis of periodontal diseases, and healing after periodontal treatment has improved significantly. Yet, the traditional methods, periodontal probing and radiographies, remain the most common methods to diagnose periodontal disease and monitor treatment. Although these approaches can produce reliable diagnostic outcomes, they generally detect disease only after significant tissue degradation thus making treatment outcome highly uncertain. Accordingly, laboratories worldwide have collaborated with clinicians to design accurate, rapid and cost-effective biomarkers for periodontal disease diagnosis. Despite these efforts, biomarkers that can be widely used in early disease diagnosis and for treatment outcome prediction are far from daily use. The aim of this chapter is to give a general overview on periodontal health and diseases, and review recent advancements in periodontal biomarker research. A second aim will discuss the strengths and limitations of translating periodontal biomarker research to clinical practice. Genetic biomarkers of periodontitis are not discussed as the available confirmatory data is scarce.

Identifiants

pubmed: 38762240
pii: S0065-2423(24)00060-X
doi: 10.1016/bs.acc.2024.03.003
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

145-168

Informations de copyright

Copyright © 2024. Published by Elsevier Inc.

Auteurs

Ulvi Kahraman Gürsoy (UK)

Periodontology, Institute of Dentistry, University of Turku, Turku, Finland. Electronic address: ulvi.gursoy@utu.fi.

Meltem Özdemir Kabalak (M)

Periodontology, Faculty of Dentistry, Hacettepe University, Ankara, Turkey.

Mervi Gürsoy (M)

Periodontology, Institute of Dentistry, University of Turku, Turku, Finland; Oral Health Care, Welfare Division, City of Turku, Turku, Finland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH